The atypical serine proteases of the complement system

Advances in Immunology

Volumn 69, Issue , 1998, Pages 249-307

  Arlaud, Gérard J ^a   Volanakis, John E ^b   Thielens, Nicole M ^a   Narayana, Sthanam V L ^c   Rossi, Véronique ^a   Xu, Yuanyuan ^b  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^b The University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; SERINE PROTEINASE;

AMINO ACID SEQUENCE; CATALYSIS; COMPLEMENT SYSTEM; CRYSTAL STRUCTURE; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE STRUCTURE; HUMORAL IMMUNITY; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0031804633     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (220)

1. Ahearn, J. M., and Fearon, D. T. (1989). Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46, 183-219.
2. Arlaud, G. J., and Gagnon, J. (1981). Clr and Cls subcomponents of human complement: two serine proteinases lacking the "histidine loop" disulphide bridge. Biosci. Rep. 1, 779-784.
3. Arlaud, G. J., and Gagnon, J. (1983). Complete amino acid sequence of the catalytic chain of human complement subcomponent Clr. Biochemistry 22, 1758-1764.
4. Arlaud, G. J., and Gagnon, J. (1985). Identification of the peptide bond cleaved during activation of human Clr. FEBS Lett. 180, 234-238.
5. Arlaud, G. J., and Thielens, N. M. (1993). Human complement serine proteases Clr and Cls and their proenzymes. In "Methods in Enzymology" (L. Lorand and K. G. Mann, eds.). Vol. 223, pp. 61-82. Academic Press, San Diego, CA.
6. Arlaud, G. J., Gagnon, J., Villiers, C. L., and Colomb, M. G. (1986). Molecular characterization of the catalytic domains of human complement serine protease Clr. Biochemistry 25, 5177-5182.
7. Arlaud, G. J., Willis, A. C, and Gagnon, J. (1987a). Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme Clr. Biochem. J. 241, 711-720.
8. Arlaud, G. J., Colomb, M. G., and Gagnon, J. (1987b). A functional model of the human CI complex. Immunol. Today 8, 106-111.
9. Arlaud, G. J., van Dorsselaer, A., Bell, M., Mancini, A., Aude, C, and Gagnon, J. (1987c). Identification of erythro-β-hydroxyasparagine in the EGF-like domain of human Clr. FEBS Lett. 222, 129-134.
10. Aruffo, A., Melnick, M. B., Linsley, P. S., and Seed, B. (1991). The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J. Exp. Med. 174, 949-952.
11. Ashfield, R., Enriquez-Harris, P., and Proudfoot, N. J. (1991). Transcriptional termination between the closely linked human complement genes C2 and factor B: Common termination factor for C2 and c-myc? EMBO J. 10, 4197-4207.
12. Bachovchin, W. W., and Roberts, J. D. (1978). Nitrogen-15 nuclear magnetic resonance spectroscopy. The state of histidine in the catalytic triad of α-lytic protease. Implications for the charge-relay mechanism of peptide-bond cleavage by serine proteases. J. Amer. Chem. Soc. 100, 8041-8047.
13. Barlow, P. N., Norman, D. G., Steinkasserer, A., Home, T. J., Pearce, J., Driscoll, P. C, Sim, R. B., and Campbell, I. D. (1992). Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31,3626-3634.
14. Barlow, P. N., Steinkasserer, A., Norman, D. G., Kieffer, B., Wiles, A. P., Sim, R. B., and Campbell, I. D., (1993). Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232, 268-284.
15. Barnum, S. R., Fey, G., and Tack, B. F. (1989). Biosynthesis and genetics of C3. Curr. Top. Microbiol. Immunol. 153, 23-43.
16. Baron, M., Norman, D., and Campbell, I. D. (1991). Protein modules. Trends Biochem. Set. 16, 13-17.
17. Bentley, D. R. (1986). Primary structure of human complement component C2: Homology to two unrelated protein families. Biochem. J. 239, 339-345.
18. Bersch, B., Hernandez, J.-F., Marion, D., and Arlaud, G. J. (1998). Solution structure of the epidermal growth factor-like module of human complement protease Clr, an atypical member of the EGF family. Biochemistry 37, 1204-1214.
19. Birktoft, J. J., and Blow, D. M., (1972). Structure of crystalline α-chymotrypsin. V. The atomic structure of tosyl-α-chymotrypsin at 2.0 Å resolution. J. Mol. Biol. 68, 187-240.
20. Blow, D. M., Birktoft, J. J., and Hartley, B. S. (1969). Role of a buried acid group in the mechanism of action of chymotrypsin. Nature (London) 221, 337-340.
21. Bork, P. (1991). Complement components Clr/Cls, bone morphogenetic protein 1 and Xenopus laevis developmentally regulated protein UVS.2 share common repeats. FEBS Lett. 282, 9-12.
22. Bork, P., and Bairoch, A. (1995). Extracellular protein modules: A proposed nomenclature. Trends Biochem. Sci. 20, (Suppl. March), C03.
23. Bork, P., and Beckmann, G. (1993). The CUB domain. A widespread module in developmentally regulated proteins. J. Mol. Biol. 231, 539-545.
24. Bork, P., Downing, A. K. Kieffer, B., and Campbell, I. D. (1996). Structure and distribution of modules in extracellular proteins. Q. Rev. Biophys. 29, 119-167.
25. Bossone, S. A., Asselin, C, Patel, A. J., and Marcu, K. B. (1992). MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc. Natl. Acad. Sci. U. S.A. 89, 7452-7456.
26. 2 subunit of first component of human complement in solution. Proc. Natl. Acad. Sci. U.S.A. 80, 3769-3773.
27. Busby, T. F., and Ingham, K. C. (1987). Calcium-sensitive transitions and domain structure of human complement subcomponent Clr. Biochemistry 26, 5564-5571.
28. Busby, T. F., and Ingham, K. C. (1988). Domain structure, stability, and interactions of human complement Cls: Characterization of a derivative lacking most of the B chain. Biochemistry 27, 6127-6135.
29. 2-terminal calcium-binding domain of human complement Cls mediates the interaction of Clr with Clq. Biochemistry 29,4613-4618.
30. Campbell, R. D., and Bentley, D. R. (1985). The structure and genetics of the C2 and factor B genes. Immunol. Rev. 87, 19-37.
31. Campbell, I. D., and Bork, P. (1993). Epidermal growth factor-like modules. Curr. Opin. Struct. Biol. 3, 385-392.
32. Carroll, M. C, Campbell, R. D., Bentley, D. R., and Porter, R. R. (1984). A molecular map of die human major histocompatibility complex class III region linking complement genes C4, C2, and factor B. Nature (London) 307, 237-241.
33. Carroll, M. C, Katzman, P., Alicot, E. M., Koller, B. H., Geraghty, D. E., Orr, H. T., Strominger, J. L., and Spies, T. (1987). Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc. Natl. Acad. Sci. U. S.A. 84,8535-8539.
34. Carter, P. E., Dunbar, B., and Fothergill, J. E. (1983). The serine proteinase chain of human complement component Cls. Biochem. J. 215, 565-571.
35. Carter, P. E., Dunbar, B., and Fothergill, J. E. (1984). Structure and activity of Clr and Cls. Philos. Trans. R. Soc. London, Ser. B 306, 293-299.
36. Catterall, C. F., Lyons, A., Sim, R. B., Day, A. J., and Harris, T. J. R. (1987). Characterization of the primary amino acid sequence of human complement control protein Factor I from an analysis of cDNA clones. Biochem. J. 242, 849-856.
37. Cohen, G. H., Silverton, E. W., and Davies, D. R. (1981). Refined crystal structure of γchymotrypsin at 1.9 Å resolution. Comparison with other pancreatic serine proteases. J. Mol. Biol. 148, 449-479.
38. Colomb, M. G., Arlaud, G. J., and Villiers, C. L. (1984). Activation of CI. Philos. Trans. R. Soc. London B 306, 283-292.
39. Colombatti, A., and Bonaldo, P. (1991). The superfamily of proteins with von Willebrand factor type A-like domains: One theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77, 2305-2315.
40. Cooper, N. R. (1975). Enzymatic activity of the second component of complement. Biochemistry 14, 4245-4251.
41. Cooper, N. R. (1985). The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37, 151-216.
42. Cooper, N. R. (1998). Complement and viruses. In "The Human Complement System in Health and Disease" (J. E. Volanakis and M. M. Frank, Eds.), pp. 393-407. Dekker, New York.
43. Craik, C. S., Roczniak, S., Largman, C, and Rutter, W. J. (1987). The catalytic role of the active site aspartic acid in serine proteases. Science 237 909-913.
44. Cross, S. J., Edwards, J. H., Bentley, D. R., and Campbell, R. D. (1985). DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2C and factor B F alleles. Immunogenetics 21, 39-48.
45. Cseh, S., Gal, P., Sarvari, M., Dobo, J., Lorincz, Z., Schumaker, V. N., and Zavodszky, P. (1996). Functional effects of domain deletions in a multidomain serine protease, Clr. Mol. Immunol. 33, 351-359.
46. Daly, N., Scanlon, M. J., Djordjevic, J. T., Kroon, P. A., and Smith, R. (1995). Three-dimensional structure of a cysteine-rich repeat from the low-density-lipoprotein receptor. Proc. Natl. Acad. Sci. U.S.A. 92, 6334-6338.
47. Davis, A. E. (1981). The C3b inactivator of the human complement system: Homology with serine proteases. FEBS Lett. 134, 147-150.
48. Davis, A. E., III, and Harrison, R. A. (1982). Structural characterization of factor I mediated cleavage of the third component of complement. Biochemistry 21, 5745-5749.
49. Davis, A. E. III, Aulak, K. S., Zahedi, K., Bissler, J. J., and Harrison, R. A. (1993). CI inhibitor. In "Methods in Enzymology, Vol. 223" (L. Lorand and K. G. Mann, Eds.), pp. 97-120. Academic Press, San Diego, CA.
50. Dias, J. M., Carvalho, A. L., Kölln, I., Calvete, J. J., Töpfer-Petersen, E., Varela, P. F., Romero, A., Urbanke, C., and Romao, M. J. (1997). Crystallisation and preliminary X-ray diffraction studies of aSFP, a bovine seminal plasma protein with a single CUB domain architecture. Protein Sci. 6, 725-727.
51. DiScipio, R. G. (1992). Formation and structure of the C5b-7 complex of the lytic pathway of complement. J. Biol. Chem. 267, 17087-17094.
52. DiScipio, R. G., Gehring, M. R., Podack, E. R., Kan, C. C, Hugli, T. E., and Fey, G. H. (1984). Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc. Natl. Acad. Sci. U.S.A. 81, 7298-7302.
53. 14C-DIP-trypsin with α-chymotrypsin. Biochim. Biophys. Acta 19, 193-195.
54. Doolittle, R. F. (1995). The multiplicity of domains in proteins. Annu. Rev. Biochem. 64, 287-314.
55. Downing, A. K., Knott, V.,Werner, J. M., Cardy, C. M., Campbell, I. D., and Handford, P. A. (1996). Solution structure of a pair of calcium-binding epidermal growth factorlike domains: implications for the marfan syndrome and other genetic disorders. Cell (Cambridge, Moss.) 85, 597-605.
56. Dunham, I, Sargent, C. A., Trowsdale, J., and Campbell, R. D. (1987). Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc. Natl. Acad. Sci. U.S.A. 84, 7237-7241.
57. Edwards, C. P., Champe, M., Gonzales, T., Wessinger, M. E., Spencer, S. A., Presta, L. G., Berman, P. W., and Bodary, S. C. (1995). Identification of amino acids in the C D l l a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1). J. Biol. Chem. 270,12635-12640.
58. Endo, Y., Sato, T., Matsushita, M., and Fujita, T. (1996). Exon structure of the gene encoding the human mannose-binding protein-associated serine protease (MASP) light chain: Comparison with complement Clr and Cls genes. Int. Immunol. 9, 1355-1358.
59. Eriksson, H.,and Nissen, M. H.(1990). Proteolysis of the heavy chain of major histocompatibility complex class I antigens by complement component Cls. Biochim. Biophys. Acta 1037, 209-215.
60. Evnin L. B., Vasquez, J. R., and Craik, C. S. (1990). Substrate specificity of trypsin investigated by using a genetic selection. Proc. Natl. Acad. Sci. U.S.A. 87, 6659-6663.
61. Fehlhammer, H., Bode, W., and Huber, R. (1977). Crystal structure of bovine trypsinogen at 1.8 A resolution. II. Crystallographic refinement, refined crystal structure, and comparison with bovine trypsin. J. Mol. Biol. 111, 414-438.
62. Fishelson, Z., and Miiller-Eberhard, H. J. (1984). Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb. J. Immunol. 132, 1425-1429.
63. Fishelson, Z., Pangburn, M. K., and Miiller-Eberhard, H. J. (1983). C3-convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex. J. Biol. Chem. 258, 7411-7415.
64. Fothergill, J. E., Kemp, G., Paton, N., Carter, P., and Gray, P. (1989). The structures of human Clr and Cls and their relationship to other serine proteases. Behring Inst. Mitt. 84, 72-79.
65. Freeman, M., Ashkenas, J., Rees, D. J. G., Kingsley, D. M., Copeland, N. G., Jenkins, N. A., and Krieger, M. (1990). An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc. Natl. Acad. Sci. U.S.A. 87, 8810-8814.
66. Fujita, T., Gigli, I., and Nussenzweig, V. (1978). Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J. Exp. Med. 148, 1044-1051.
67. Goldberger, G., Amaout, M. A., Aden, D., Kay, R., Rits, M., and Colten. H. R. (1984). Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (Factor I) in three hepatoma cell lines. J. Biol. Chem. 259, 6492-6497.
68. Goldberger, G., Bruns, G. A. P., Rits, M., Edge, M. D., and Kwiatkowski, D. J. (1987). Human complement factor I: Analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4. J. Biol. Chem. 262,10065-10071.
69. Graf, L., Jancso, A., Szilagyi, L., Hegyi, G., Pinter, K., Naray-Szabo, G., Hepp, J., Medzihradszky, K., and Rutter, W. J. (1988). Electrostatic complementarity in the substrate binding pocket of trypsin. Proc. Natl. Acad. Sci. U.S.A. 85, 4961-4965.
70. Greer, J. (1990). Comparative modeling methods: Application to the family of the mammalian serine proteases. Proteins Struct. Fund. Genet. 7, 317-334.
71. Haefliger, J.-A., Tschopp, J., Vial, N., and Jenne, D. E. (1989). Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6. J. Biol. Chem. 264,18041-18051.
72. Hedstrom, L., Szilagyi, L., and Rutter, W. J. (1992). Converting trypsin to chymotrypsin: The role of surface loops. Science 255, 1249-1253.
73. Hedstrom L, Perona, J. J., and Rutter, W. J. (1994). Converting trypsin to chymotrypsin: Residue 172 is a substrate specificity determinant. Biochemistry 33, 8757-8763.
74. Hernandez, J.-F., Bersch, B., Petillot, Y., Gagnon, J., and Arlaud, G. J. (1997). Chemical synthesis and characterization of the epidermal growth factor-like module of human complement protease Clr. J. Peptide Bes. 49, 221-231.
75. Hess, D., Schaller, J., and Rickli, E. E. (1991). Identification of the disulfide bonds in human complement Cls. Biochemistry 30, 2827-2833.
76. Horiuchi, T., Macon, K. J., Kidd, V. J., and Volanakis, J. E. (1989). cDNA cloning and expression of human complement component C2. J. Immunol. 142, 2105-2111.
77. Horiuchi, T., Macon, K. J., Engler, J. A., and Volanakis, J. E. (1991). Site-directed mutagenesis of the region around Cys-241 of complement component C2: Evidence for a C4bbinding site. J. Immunol. 147, 584-589.
78. Horiuchi, T., Kim, S., Matsumoto, M„ Watanabe, I., Fujita, S., and Volanakis, J. E. (1993). Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis, and expression. Mol. Immunol. 30, 1587-1592.
79. Hourcade, D. E., Wagner, L. M., and Oglesby, T. J. (1995). Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis. J. Biol. Chem. 270, 19716-19722.
80. Ikari, N., Hitomi, Y., Ninobe, M., and Fujii, S. (1983). Studies on esterolytic activity of alternative complement component factor B. Biochim. Biophys. Acta 742, 318-323.
81. 2+-dependent interactions of human Cls. Location of the iodination sites. Biochemistry 30, 7135-7141.
82. Illy, C, Thielens, N. M., and Arlaud, G. J. (1993). Chemical characterization and location of ionic interactions involved in the assembly of the CI complex of human complement. J. Trot. Chem. 12, 771-781.
83. Ishii, Y., Zhu, Z.-B., Macon, K. J., and Volanakis, J. E. (1993). Structure of the human C2 gene. J. Immunol. 151, 170-174.
84. Ji, X., Azumi, K., Sasaki, M., and Nonaka, M. (1997). Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan-binding protein-associated serine protease from a urochordate, the Japanese ascidian Halocynthia roretzi. Proc. Natl. Acad. Sci. U.S.A. 94, 6340-6345.
85. Ji, Y.-H., Fujita, T., Hatsuse, H., Takahashi, A., Matsushita, M., and Kawakami, M. (1993). Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor. J. Immunol. 150, 571-578.
86. Johnson, D. M. A., Gagnon, J., and Reid, K. B. M. (1984). Amino acid sequence of human factor D of the complement system. Similarity in sequence between factor D and proteases of non-plasma origin. FEBS Lett. 166, 347-351.
87. Journet, A., and Tosi, M. (1986). Cloning and sequencing of full-length cDNA encoding the precursor of human complement component Clr. Biochem. J. 240, 783-787.
88. Kam, C.-M., McRae, B. J., Harper, J. W., Niemann, M. A., Volanakis, J. E., and Powers, J. C. (1987). Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates. J. Biol. Chem. 262, 3444-3451.
89. Kam, C.-M., Fujikawa, K,. and Powers, J. C. (1988). Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: New anticoagulants. Biochemistry 27, 2547-2557.
90. Kam, C.-M., Oglesby, T. J., Pangburn, M. K., Volanakis, J. E., and Powers, J. C. (1992). Substituted isocoumarins as inhibitors of complement serine proteases. J. Immunol. 149, 163-168.
91. Kamata, T., Wright, R., and Takada, Y. (1995). Critical threonine and aspartic acid residues within the I domains of β2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J. Biol Chem. 270, 12531-12535.
92. Kamboh, M. I., and Ferrell, R. E. (1986). Genetic studies of low abundance human plasma proteins. III. Polymorphism of the Clr subcomponent of the first complement component. Am. J. Hum. Genet. 39, 826-831.
93. Kerr, M. A. (1980). The human complement system. Assembly of the classical pathway C3-convertase. Biochem. J. 189, 173-181.
94. Kim, S., Narayana, S. V. L., and Volanakis, J. E. (1994). Mutational analysis of the substrate binding site of human complement factor D. Biochemistry 33, 14393-14399.
95. Kim, S., Narayana, S. V. L., and Volanakis, J. E. (1995a). Catalytic role of a surface loop of the complement serine protease factor D. J. Immunol. 154, 6073-6079.
96. Kim, S., Narayana, S. V. L., and Volanakis, J. E. (1995b). Crystal structure of a complement factor D mutant expressing enhanced catalytic activity. J. Biol. Chem. 270, 24399-24405.
97. Kossiakoff, A. A., and Spencer, S. A. (1981). Direct determination of the protonation states of aspartic acid-102 and histidine-57 in the tetrahedral intermediate of the serine proteases: Neutron structure of trypsin. Biochemistry 20, 6462-6474.
98. Kraulis, P. J. (1991). MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
99. Krych, M., Hourcade, D., and Atkinson, J. P. (1991). Sites within the C3b/C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. U.S.A. 88,4353-4357.
100. Kusumoto, H., Hirosawa, S., Salier, J. P., Hagen, F. S., and Kurachi, K. (1988). Human genes for complement components Clr and Cls in a close tail-to-tail arrangement. Proc. Natl. Acad. Sci. U.S.A. 85, 7307-7311.
101. Lachmann, P. J., and Nicol, P. A. E. (1973). Reaction mechanisms of the alternative pathway of complement fixation. Lancet 1, 465-467.
102. Lacroix, M., Rossi, V., Gaboriaud, C, Chevallier, S., Jaquinod, M., Thielens, N. M., Gagnon, J., and Arlaud, G. J. (1997). Structure and assembly of the catalytic region of human complement protease Clr: a three-dimensional model based on chemical cross-linking and homology modeling. Biochemistry 36, 6270-6282.
103. Lacroix, M. B., Aude, C. A., Arlaud, G. J., and Colomb, M. G. (1989). Isolation and functional characterization of the proenzyme form of the catalytic domains of human Clr. Biochem. J. 257, 885-891.
104. Lakatos, S. (1987). Subunit interactions in the first component of complement, CI. Biochem. Biophys. Res. Commun. 149, 378-384.
105. Lambris, J. D., and Müller-Eberhard, H. J. (1984). Isolation and characterization of a 33,000-Dalton fragment of complement factor B with catalytic and C3b binding activity. J. Biol. Chem. 259, 12685-12690.
106. Lee, J. O., Rieu, P., Arnaout, M. A., and Liddington, R. (1995a). Crystal structure of the A domain from the α subunit of integrin CR3 (CDllb/CD18). Cell (Cambridge, Mass.) 80, 631-638.
107. Lee, J.-O., Bankston, L. A., Arnaout, M. A., and Liddington, R. C. (1995b). Two conformations of the integrin A-domain (I-domain): A pathway for activation? Structure 3, 1333-1340.
108. Lesavre, P. H., and Müller-Eberhard, H. J. (1978). Mechanism of action of factor D of the alternative complement pathway. J. Exp. Med. 148, 1498-1509.
109. Leytus, S. P., Kurachi, K., Sakariassen, K. S., and Davie, E. W. (1986). Nucleotide sequence of the cDNA coding for human complement Clr. Biochemistry 25, 4855-4863.
110. Liszewski, M., Farrier, T., Lublin, D., Rooney, I., and Atkinson, J. (1996). Control of the complement system. Adv. Immunol. 61, 201-283.
111. Loos, M., and Heinz, H. P. (1986). Complement deficiencies 1. The first component: Clq, Clr, Cls. Prog. Allergy 39, 212-231.
112. 2 complex of the classical pathway of complement, without involvement of Clq. J. Immunol. 144, 2287-2294.
113. Luo, C, Thielens, N. M., Gagnon, J., Gal, P., Sarvari, M., Tseng, Y., Tosi, M., Zavodszky, P., Arlaud, G. J., and Schumaker, V. N. (1992). Recombinant human complement subcomponent Cls lacking β-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with Clq and Clr to form a functional CI complex. Biochemistry 31, 4254-4262.
114. Mackinnon, C. M., Carter, P. E., Smith, S. J., Dunbar, B., and Fothergill, J. E. (1987). Molecular cloning of cDNA for human complement component Cls. The complete amino acid sequence. Eur. J. Biochem. 169, 547-553.
115. Matsumoto, M., and Nagaki, K. (1986). Functional analysis of activated Cls, a subcomponent of the first component of human complement, by monoclonal antibodies. J. Immunol. 137, 2907-2912.
116. Matsumoto, M., Nagaki, K., Kitamura, H., Kuramitsu, S., Nagasawa, S., and Seya, T. (1989). Probing the C4-binding site on Cls with monoclonal antibodies. Evidence for a C4/C4bbinding site on the gamma domain. J. Immunol. 142, 2743-2750.
117. Matsushita, M., and Fujita, T. (1992). Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J. Exp. Med. 176, 1497-1502.
118. Matsushita, M. and Fujita, T. (1995). Cleavage of the third component of complement by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. Immunohiology 194, 443-448.
119. Matsushita, M., and Fujita, T. (1996). Inhibition of mannose-binding protein-associated serine protease (MASP) by CI inhibitor (CI INH). Mol. Immunol. 33, 44 (abstract).
120. McRae, B. J., Lin, T.-Y., and Powers, J. C. (1981). Mapping the substrate binding site of human Clr and Cls with peptide thioesters: Development of new sensitive substrates. J. Biol. Chem. 256, 12362-12366.
121. Medof, M. E., Iida, K., Mold, C, and Nussenzweig, V. (1982). Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 156, 1739-1754.
122. Medved, L. V., Busby, T. F., and Ingham, K. C. (1989). Calorimetric investigation of the domain structure of human complement Cls: Reversible unfolding of the short consensus repeat units. Biochemistry 28, 5408-5414.
123. Michishita, M., Videm, V., and Arnaout, A. (1993). A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CDllb/CD18) is essential for ligand binding. Cell (Cambridge, Mass.) 72, 857-867.
124. Min, H. Y., and Spiegelman, B. M. (1986). Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor. Nucleic Acids Res. 14,8879-8892.
125. Mole, J. E., Anderson, J. K., Davison, E. A., and Woods, D. E. (1984). Complete primary structure for the zymogen of human complement factor B. J. Biol. Chem. 259,3407-3412.
126. Morgan, B. P., and Walport, M. J. (1991). Complement deficiency and disease. Immunol. Today 12, 301-306.
127. Nagasawa, S., and Stroud, R. M. (1977). Cleavage of C2 by CI into the antigenically distinct fragments C2a and C2b: Demonstration of binding of C2b to C4. Proa Nad. Acad. Set. U.S.A. 74, 2998-3001.
128. Nagasawa, S., Kobayashi, C, Maki-Suzuki, T., Yamashita, N., and Koyama, J. (1985). Purification and characterization of the C3-convertase of the classical pathway of human complement system by size exclusion high-performance liquid chromatography. J. Biochem. 97, 493-499.
129. Narayana, S. V. L., Carson, M., El-Kabani, O., Kilpatrick, J. M„ Moore, D., Chen, X., Bugg, C. E., Volanakis, J. E., and DeLucas, L. J. (1994). Structure of human factor D, a complement system protein at 2.0 resolution. J. Mol. Biol. 235, 695-708.
130. Niemann, M. A., Bhown, A. S., Bennett, J. C, and Volanakis, J. E. (1984). Amino acid sequence of human factor D of the alternative complement pathway. Biochemistry 23, 2482-2486.
131. Nilsson-Ekdahl, K., Nilsson, U. R., and Nilsson, B. (1990). Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I. J. Immunol. 144, 4269-4274.
132. Nissen, M. H., Roepstorff, P., Thim, L., Dunbar, B., and Fothergill, J. E. (1990). Limited proteolysis of β2-microglobulin at Lys-58 by complement component Cls. Eur. J. Biochem. 189, 423-429.
133. Norman, D. C, Barlow, P. N„ Baron, M., Day, A. J., Sim, R. B., and Campbell, I. D. (1991). Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219, 717-725.
134. Ogata, R. T., Low, P. J., and Kawakami, M. (1995). Substrate specificities of the protease of mouse serum Ra-reactive factor. J. Immunol. 154, 2351-2357.
135. Oglesby, T. J., Accavitti, M. A., and Volanakis, J. E. (1988). Evidence for a C4b binding site on the C2b domain of C2. J. Immunol. 141, 926-931.
136. Pangburn, M. K., and Miiller-Eberhard, H. J. (1986). The C3-convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem. J. 235, 723-730.
137. Pangburn, M. K., Schreiber, R. D., and Muller-Eberhard, H. J. (1981). Formation of the initial C3-convertases of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154, 856-867.
138. Parkes, C, Gagnon, J., and Kerr, M. A. (1983). The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Biochem. J. 213,201-209.
139. Pascual, M., Steiger, G., Estreicher, J., Macon, K., Volanakis, J. E., and Schifferli, J. A. (1988). Metabolism of complement factor D in renal failure. Kidney Int. 34, 529-536.
140. Patthy, L. (1991). Exons-original building blocks of proteins. Bioessays 13, 187-192.
141. Patthy, L. (1993). Modular design of proteases of coagulation, fibrinolysis, and complement activation: implications for protein engineering and structure-function studies. In "Methods in Enzymology, Vol. 222" (L. Lorand and K. G. Mann, Eds.), pp. 10-21. Academic Press, San Diego, CA.
142. Patthy, L. (1994). Introns and exons. Curr. Opin. Struct. Biol. 4, 383-392.
143. Perkins, S. J. (1989). Models for the CI complex determined by physical techniques. Behring Inst. Mitt. 84, 129-141.
144. Perkins, S. J., and Smith, K. F. (1993). Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures. Biochem. J. 295, 109-114.
145. 2 within CI. J. Mol. Biol. 179, 547-557.
146. Perkins, S. J., Smith, K. F., Williams, S. C, Haris, P. I., Chapman, D., and Sim, R. B. (1994). The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. J. Mol. Biol. 238, 104-119.
147. Perona, J. J., and Craik, C. S. (1995). Structural basis of substrate specificity in the serine proteases. Protein Sci. 4, 337-360.
148. Perona, J. J., Hedstrom, L., Wagner, R., Rutter, W. J., Craik, C. S., and Fletterick, R. J. (1994). Exogenous acetate reconstitutes the enzymatic activity of Aspl89Ser trypsin. Biochemistry 33, 3252-3259.
149. Perona J. J., Hedstrom, L., Rutter, W. J., and Fletterick, R. J. (1995). Structural origins of substrate discrimination in trypsin and chymotrypsin. Biochemistry 34, 1489-1499.
150. Petillot, Y., Thibault, P. Thielens, N. M., Rossi, V., Lacroix, M., Coddeville, B., Spik, G., Schumaker, V. N., Gagnon, J., and Arlaud, G. J. (1995). Analysis of the N-linked oligosaccharides of human Cls using electrospray ionisation mass spectrometry. FEBS Lett. 358, 323-328.
151. Polley, M. J., and Müller-Eberhard, H. J. (1967). Enhancement of the hemolytic activity of the second component of human complement by oxidation.J. Exp. Med. 126,1013-1025.
152. Pryzdial, E. L. G., and Isenman, D. E. (1987). Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact. J. Biol. Chem. 262, 1519-1525.
153. Qu, A., and Leahy, D. J. (1995). Crystal structure of the I-domain from the CDlla/CD18 (LFA-1, Α1Β2) integrin. Proc. Natl. Acad. Sci. U.S.A. 92, 10277-10281.
154. 2+-binding epidermal growth factor-like domain: its role in protein-protein interactions. Cell (Cambridge, Mass.) 82, 131-141.
155. Reid, K. B. M. (1995). The complement system. A major effector mechanism in humoral immunity. Immunologist 3, 206-211.
156. Reid, K. B. M., Bentley, D. R., Campbell, R. D., Chung, L. P., Sim, R. B.,Kristensen, T., and Tack, B. F. (1986). Complement system proteins which interact with C3b and C4b. A superfamily of structurally related proteins. Immunol. Today 7, 230-234.
157. Rogers, J. (1985). Exon shuffling and intron insertion in serine protease genes. Nature (London) 315, 458-459.
158. Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., Ward, P., and Lieberburg, I. (1992). Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 89, 10016-10020.
159. Rossi, V., Gaboriaud, C, Lacroix, M., Ulrich, J., Fontecilla-Camps, J. C, Gagnon, J., and Arlaud, G. J. (1995). Structure of the catalytic region of human complement protease Cls: Study by chemical cross-linking and three-dimensional homology modeling. Biochemistry 34, 7311-7321.
160. Rossi, V., Bally, I., Thielens, N. M., Esser, A. F., and Arlaud, G. J. (1998). Baculovimsmediated expression of truncated modular fragments from the catalytic region of human complement serine protease Cls. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. J. Biol. Chem. 273, 1232-1239.
161. Sánchez-Corral, P., Antón, L. C, Alcolea, J. M., Marqués, G., Sánchez, A., and Vivanco, F. (1990). Proteolytic activity of the different fragments of factor B on the third component of complement (C3): Involvement of the N-terminal domain of Bb in magnesium binding. Mol. Immunol. 27, 891-900.
162. Sato, T., Endo, Y., Matsushita, M., and Fujita, T. (1994). Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int. Immunol. 6, 665-669.
163. Sawyer, L., Shotton, D. M., Campbell, J. W., Wendell, P. L., Muirhead, H., Watson, H. C, Diamond, R., and Ladner, R. C. (1978). The atomic structure of crystalline porcine pancreatic elastase at 2.5 resolution. Comparison with the structure of α-chymotrypsin. J. Mol. Biol. 118, 137-208.
164. Schechter, I., and Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
165. Schumaker, V. N., Zavodszky, P., and Poon, P. H. (1987). Activation of the first component of complement. Ann. Rev. Immunol. 5, 21-42.
166. Selander-Sunnerhagen, M., Persson, E., Dahlqvist, I., Drakenberg, T., Stenflo, J., Mayhew, M., Robin, M., Handford, P., Tilley, J. W., Campbell, I. D., and Brownlee, G. G. (1993). The effect of aspartate hydroxylation on calcium binding to epidermal growth factor-like modules in coagulation factors IX and X. J. Biol. Chem. 268, 23339-23344.
167. Seya, T., Nakamura, K., Masaki, T., Ichihara-Itoh, C, Matsumoto, M., and Nagasawa, S. (1995). Human factor H and C4b-binding protein serve as factor I-cofactors both encompassing inactivation of C3b and C4b. Mol. Immunol. 32, 355-360.
168. Shaw, E., Mares-Guia, M., and Cohen, W. (1965). Evidence for an active site histidine in trypsin through use of a specific reagent, l-chloro-3-tosylamido-7-amino-2-heptanone, the chloromethyl ketone derived from Nα-tosyl-L-Iysine. Biochemistry 4, 2219-2224.
169. Shiang, R., Murray, J. C, Morton, C. C, Buetow, K. H., Wasmuth, J. J,, Obey, A. H„ Sanger, W. G., and Goldberger, G. (1989). Mapping of the human complement factor I gene to 4q25. Genomics 4, 82-86.
170. 2 tetramer. Mol. Immunol, 20, 53-66.
171. Sim, R. B., Porter, R. R., Reid, K. B. M., and Gigli, I. (1977). The structure and enzymic activities of the Clr and Cls subcomponents of CI, the first component of human serum complement. Biochem. J. 163, 219-227.
172. Sim, R. B., Arlaud, G. J., and Colomb, M. G. (1979). CI inhibitor-dependent dissociation of human complement component CI bound to immune complexes. Biochem. J. 179, 449-457.
173. Smith, C. A., Vogel, C.-W., and Miiller-Eberhard, H. J. (1984). MHC class III products: An electron microscopic study of the C3-convertases of human complement. J. Exp. Med. 159, 324-329.
174. Spycher, S. E., Nick, H., and Rickli, E. E. (1986). Human complement component Cls. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation. Eur. J. Biochem. 156, 49-57.
175. Stanley, K. K., Kocher, H. P., Luzio, J. P., Jackson, P., Tschopp, J., and Dickson, J. (1985). The sequence and topology of human component C9. EMBO J. 4, 375-382.
176. Steiner, D. F., Smeekens, S. P., Ohagi, S., and Chan, S. J. (1992). The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267, 23435-23438.
177. Strang, C. J., Siegel, R. C, Phillips, M. L., Poon, P. H., and Schumaker, V. N. (1982). Ultrastructure of the first component of human complement: electron microscopy of the cross-linked complex. Proc. Natl. Acad. Sci. U.S.A. 79, 586-590.
178. Stroud, R. M., Krieger, M., Koeppe, II, R. E., Kossiakoff, A. A., and Chambers, J. L. (1975). Structure-function relationships in the serine proteases. Cold Spring Harbor Conf. Cell Proliferation 2, 13-32.
179. Sudhof, T. C, Goldstein, J. L., Brown, M. S., and Russell, D. W. (1985). The LDL receptor gene: a mosaic of exons shared with different proteins. Science 228, 815-822.
180. 2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study. Biochemistry 35, 11547-11559.
181. Takada, F., Takayama, Y., Hatsuse, H., and Kawakami, M. (1993). A new member of the Cls family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum. Biochem. Biophys. Res. Commun. 196, 1003-1009.
182. Takada, F., Seki, N., Matsuda, Y. I., Takayama, Y., and Kawakami, M. (1995). Localization of the genes for the 100-kDa complement-activating components of Ra-reactive factor to human 3q27-q28 and mouse 16B2-B3. Genomics 25, 757-759.
183. Takahashi, A., Takayama, Y., Hatsuse, H., and Kawakami, M. (1993). Presence of a serine protease in the complement-activating component of the complement-dependent bactericidal factor, RaRF, in mouse serum. Biochem. Biophys. Res. Commun. 190, 681-687.
184. Takayama, Y., Takada, F., Takahashi, A., and Kawakami, M. (1994). A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to Clr and Cls. J. Immunol. 152, 2308-2316.
185. 2-macroglobulm binds to and inhibits mannose-binding protein-associated serine protease. Int. Immunol. 10, 1579-1584.
186. t Willis, A. C, Eggleton, P., Hansen, S., Holmskov, U., Reid, K. B. M., and Jensenius, J. C. (1997). A second serine protease associated with mannan-binding lectin that activates complement. Nature (London) 386, 506-510.
187. Thielens, N. M., van Dorsselaer, A., Gagnon, J., and Arlaud, G. J. (1990a). Chemical and functional characterization of a fragment of Cls containing the epidermal growth factor homology region. Biochemistry 29, 3570-3578.
188. 2-terminal a fragments of human complement proteases Clr and Cls. J. Biol. Chem. 265, 14469-14475.
189. Thielens, N. M., Illy, C, Bally, I. M., and Arlaud, G. J. (1994). Activation of human complement serine proteinase Clr is down-regulated by a calcium-dependent intramolecular control that is released in the CI complex through a signal transmitted by Clq. Biochem. J. 301, 378-384.
190. Tomana, M., Niemann, M., Garner, C, and Volanakis J. E. (1985). Carbohydrate composition of the second, third, and fifth components and factors B and D of human complement. Mol. Immunol. 22, 107-111.
191. Tosi, M., Duponchel, C, Meo, T., and Julier, C. (1987). Complete cDNA sequence of human complement Cls and close physical linkage of the homologous genes Cls and Clr. Biochemistry 26, 8516-8524.
192. Tosi, M., Duponchel, C, and Meo, T. (1989). Complement genes Clr and Cls feature an intronless serine protease domain closely related to haptoglobin. J. Mol. Biol. 208, 709-714.
193. Tschopp, J„ Villiger, W., Fuchs, H., Kilchherr, E, and Engel, J. (1980). Assembly of subcomponents Clr and Cls of first component of complement: Electron microscopy and ultracentrifugal studies. Proc. Natl. Acad. Sci. U.S.A. 77, 7014-7018.
194. Tuckwell, D. S., Xu, Y., Newham, P., Humphries, M. J., and Volanakis, J. E. (1997). Surface loops adjacent to the putative cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity. Biochemistry 36, 6605-6613.
195. Ueda A., Kearney, J. F., Roux, K. H., and Volanakis, J. E. (1987). Probing functional sites on complement protein B with monoclonal antibodies.J. Immunol. 138, 1143-1149.
196. Van Cong, M. F., Tosi, N., Gross, M., Cohen-Haguenauer, M. S., Jegou-Foubert, O., de Tand, C, Meo, T., and Frezal, J. (1988). Assignment of the complement serine protease genes Clr and Cls to chromosome 12 region 12pl3. Hum. Genet. 78, 363-368.
197. Vernet, T., Tessier, D. C, Richardson, C, Laliberte, F., Khouri, H. E., Bell, A. W., Storer, A. C, and Thomas, D. Y. (1990). Secretion of functional papain precursor from insect cells. Requirement for iV-glyeosylation of the pro-region.J. Biol Chem. 265,16661-16666.
198. Villiers, C. L., Chesne, S., Lacroix, M. B., Arlaud, G. J., and Colomb, M. G. (1982). Structural features of the first component of human complement, CI, as revealed by surface iodination. Biochem. J. 203, 185-191.
199. Villiers, C. L., Arlaud, G. J., and Colomb, M. G, (1985). Domain structure and associated functions of subcomponents Clr and Cls of the first component of human complement. Proc. Natl. Acad. Sci. U.S.A. 82, 4477-4481.
200. Volanakis, J. E. (1990). Participation of C3 and its ligands in complement activation. Curr. Top. Microbiol. Immunol. 153, 1-21.
201. Volanakis, J. E., and Macon, K. J. (1987). Isolation of complement protein D from urine of patients with Fanconi's syndrome. Anal. Biochem. 163, 242-246.
202. Volanakis, J. E., and Narayana, S. V. L. (1996). Complement factor D, a novel serine protease. Protein Sci. 5, 553-564.
203. Volanakis, J. E., Bhown, A. S., Bennett, J. C, and Mole, J. E. (1980). Partial amino acid sequence of human factor D: Homology with serine proteases. Proc. Natl. Acad. Sci. U.S.A. 77, 1116-1119.
204. Volanakis, J. E., Barnum, S. R., Giddens, M., and Galla, J. H. (1985). Renal filtration and catabolism of complement protein D. N. Engl. J. Med. 312, 395-399.
205. Vyse, T. J., Bates, G. P., Walport, M. J., and Morley, B. J. (1994). The organization of the human complement factor I gene (IF): A member of the serine protease gene family. Genomics 24, 90-98.
206. Warshel, A., Naray-Szabo, G., Sussman, F., and Hwang, J. K. (1989). How do serine proteases really work? Biochemistry 28, 3629-3637.
207. Weiss, V., Fauser, C, and Engel, J. (1986). Functional model of subcomponent CI of human complement. J. Mol. Biol. 189, 573-581.
208. 444→Arg) cause impaired C2 secretion.J. Biol. Chem. 271, 5824-5831.
209. Wharton, K. A., Johansen, K. M., Xu, T., and Artavanis-Tsakonas, S. (1985). Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell (Cambridge, Mass.) 43, 567-581.
210. White, R. T., Damm, D, Hancock, N., Rosen, B. S.,Lowell, B. B., Usher, P., Flier, J. S. and Spiegelman, B. M. (1992). Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J. Biol. Chem. 267, 9210-9213.
211. Wu, L.-C, Morley, B. J., and Campbell, R. D. (1987). Cell-specific expression of the human complement protein B gene: Evidence for the role of two distinct 5'-flanking elements. Cell (Cambridge, Mass.) 48, 331-342.
212. Xu, Y., and Volanakis, J. E. (1997). Contribution of the complement control protein modules of C2 in C4b binding assessed by analysis of C2/factor B chimeras.J. Immunol. 158,5958-5665.
213. Yamaguchi, K., Sakiyama, H., Matsumoto, M., Moriya, H., and Sakiyama, S. (1990). Degradation of type I and II collagen by human Cls. FEBS Lett. 268, 206-208.
214. Yamauchi, Y., Stevens, J. W., Macon, K. J., and Volanakis, J. E. (1994). Recombinant and native zymogen forms of human complement factor D.J. Immunol. 152, 3645-3653.
215. Yuan, J.-M., Hsiung, L.-M., and Gagnon, J. (1986). CNBr cleavage of the light chain of human complement Factor I and alignment of the fragments. Biochem. J. 233, 339-345.
216. Zavodszky, P., Gal, P., Cseh, S., and Schumaker, V. N. (1993). Protein engineering studies on Clr and Cls. Behring Inst. Mitt. 93, 103-114.
217. Zhu, Z.-B., and Volanakis, J. E. (1990). Allelic associations of multiple restriction fragment length polymorphisms of the gene encoding complement protein C2. Am. J. Hum. Genet. 46, 956-962.
218. Zhu, Z.-B., Hsieh, S. L., Bentley, D. R., Campbell, R. D., and Volanakis, J. E. (1992). A variable number of tandem repeats (VNTR) locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J. Exp. Med. 175, 1783-1787.
219. Zhu, Z.-B., Jian, B., and Volanakis, J. E. (1994). Ancestry of SINE-R.C2 a human-specific retroposon. Hum. Genet. 93, 545-551.
220. Ziccardi, R. J., and Cooper, N. R. (1979). Active disassembly of the first complement component, C1, by C1 inactivator. J. Immunol. 123, 788-792.